Literature DB >> 11004300

Blepharoptosis-induced superior keratoconus.

T Kim1, B Khosla-Gupta, C Debacker.   

Abstract

PURPOSE: This clinical case report demonstrates blepharoptosis-induced corneal steepening and its subsequent resolution after blepharoptosis surgery.
METHODS: A 62-year-old man complaining of blurred vision without apparent cause on clinical examination underwent keratometry and computerized corneal topography, which revealed superior corneal steepening in both eyes. Bilateral upper eyelid blepharoptosis surgery was performed.
RESULTS: Three months after blepharoptosis surgery, repeat computerized corneal topography revealed normal corneal contours with improved vision in both eyes.
CONCLUSIONS: Blepharoptosis is a common condition that may induce superior corneal ectasia that is not evident by manifest refraction, slit-lamp examination, or keratometry. Computerized corneal topography can help detect such subtle corneal abnormalities and guide therapy.

Entities:  

Mesh:

Year:  2000        PMID: 11004300     DOI: 10.1016/s0002-9394(00)00497-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Superior keratoconus with hydrops.

Authors:  Napaporn Tananuvat; Prasert Leeungurasatien; Captain Wiriyaluppa
Journal:  Int Ophthalmol       Date:  2008-07-10       Impact factor: 2.031

2.  Bilateral superior keratoconus: two case reports.

Authors:  G J Rogers; M Attenborough
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

3.  Factors associated with corneal astigmatism change after ptosis surgery.

Authors:  Natpatsorn Mongkolareepong; Nattapong Mekhasingharak; Oranicha Pimpha
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

4.  Combined accelerated corneal collagen crosslinking and intrastromal Kerarings implantation for treatment of advanced superior keratoconus.

Authors:  Amr Mounir; Engy Mohamed Mostafa
Journal:  GMS Ophthalmol Cases       Date:  2020-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.